Additionally, sequence variations in the promoter regions of CCL19 and CCL21 have been associated with an increased susceptibility to myocardial infarction (48), while genetic predisposition to elevated circulating levels of CCL2 correlates with a heightened risk of stroke (49). Here, CCL21 is linked to stroke disorder.